- Home
- MIST vs SBFM Comparison
MIST vs SBFM Comparison
Compare MIST & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- SBFM
- Stock Information
- Founded
- MIST 2003
- SBFM 2006
- Country
- MIST Canada
- SBFM United States
- Employees
- MIST N/A
- SBFM N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- MIST Health Care
- SBFM Health Care
- Exchange
- MIST Nasdaq
- SBFM Nasdaq
- Market Cap
- MIST N/A
- SBFM 4.9M
- IPO Year
- MIST N/A
- SBFM N/A
- Fundamental
- Price
- MIST $1.14
- SBFM $1.48
- Analyst Decision
- MIST Strong Buy
- SBFM Strong Buy
- Analyst Count
- MIST 2
- SBFM 1
- Target Price
- MIST $9.50
- SBFM $15.00
- AVG Volume (30 Days)
- MIST 4.3M
- SBFM 4.3M
- Earning Date
- MIST 05-12-2025
- SBFM 05-19-2025
- Dividend Yield
- MIST N/A
- SBFM N/A
- EPS Growth
- MIST N/A
- SBFM N/A
- EPS
- MIST N/A
- SBFM N/A
- Revenue
- MIST N/A
- SBFM $34,874,283.00
- Revenue This Year
- MIST N/A
- SBFM $192.48
- Revenue Next Year
- MIST N/A
- SBFM N/A
- P/E Ratio
- MIST N/A
- SBFM N/A
- Revenue Growth
- MIST N/A
- SBFM 44.75
- 52 Week Low
- MIST $0.63
- SBFM $1.17
- 52 Week High
- MIST $2.75
- SBFM $33.60
- Technical
- Relative Strength Index (RSI)
- MIST 48.84
- SBFM 41.28
- Support Level
- MIST $0.77
- SBFM $1.17
- Resistance Level
- MIST $0.88
- SBFM $1.59
- Average True Range (ATR)
- MIST 0.08
- SBFM 0.20
- MACD
- MIST 0.07
- SBFM 0.01
- Stochastic Oscillator
- MIST 91.89
- SBFM 33.40
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.